The Billion Cell Atlas, backed by Eli Lilly, MSD and AstraZeneca, maps mechanisms to support informed drug discovery.

Illumina has unveiled a database of genomic alterations, called the Billion Cell Atlas, that can be used to identify and validate drug targets and train AI models used in drug discovery.

The San Diego firm took a step in that direction on Tuesday, when it unveiled what it says will be the world’s largest dataset of its kind, the Billion Cell Atlas. The atlas is based on the results of ...

Devyser today announced that it entered a strategic agreement with Illumina, a global leader in DNA sequencing and array-based technologies, to provide Illumina sequencing instruments and related prod ...

Researchers are now exploring how to best extract and use saliva-derived DNA for long-read sequencing applications. Download ...

At ASHG, an early access customer from the London Health Sciences Center Research Institute will demonstrate the power of the 5-base genome for accelerating resolution of rare disease cases ...

Illumina, Inc. ILMN and Nashville Biosciences, LLC (NashBio) recently announced that 250,000 whole genomes have been sequenced for the Alliance for Genomic Discovery (AGD) initiative. The insights ...

SPT Labtech, a global leader in life sciences automation solutions, today announced its inclusion in an Illumina partnership program to develop Illumina Qualified automated library prep methods, ...

GUILDFORD, SURREY / ACCESS Newswire / January 29, 2025 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) solutions for use in ...

An announcement from Illumina ( (ILMN) ) is now available.

SHANGHAI (Reuters) -China announced a ban on Tuesday on imports of genetic sequencers from U.S. medical equipment maker Illumina, just minutes after U.S. President Donald Trump's additional 10% tariff ...